抗击新型冠状病毒感染的现状

G. Aktas
{"title":"抗击新型冠状病毒感染的现状","authors":"G. Aktas","doi":"10.21089/njhs.62.0044","DOIUrl":null,"url":null,"abstract":"The lives of billions in the world have become to change by the end of 2019, almost two years ago, after novel coronavirus (Covid-19) infection emerged in Wuhan, China. Covid-19 caused about 33 millions of infection and 1000040 deaths worldwide within 10 months of the pandemic [1]. By December 18th of 2021, number of the infected subjects and deaths rose up to 274 million and 5364119, respectively [2]. Despite its devastating effect on human life, not even a single drug has shown significant enough efficacy against Covid-19 to change the course of the pandemic. However, some new agents and repurposed drugs were able to show efficacy to some extent. In the past 2 years, we have noticed that many Covid-19 cases have actually recovered without any treatment other than general measures. Indeed, most young and middle-aged people survive the disease mildly, yet the disease can be severe in people with advanced age and who have significant additional comorbidities. That’s why, one of the most important things to do while waiting for the pandemic to end is to take and maintain measures to prevent the spread of Covid-19 in societies. Nevertheless, as the outbreak progressed, we began to consider Covid-19-related deaths as ordinary. Unfortunately, we also loosen the tight measures to control the disease.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"72 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Current Situation in the Struggle against Novel Coronavirus Infection (Covid-19)\",\"authors\":\"G. Aktas\",\"doi\":\"10.21089/njhs.62.0044\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The lives of billions in the world have become to change by the end of 2019, almost two years ago, after novel coronavirus (Covid-19) infection emerged in Wuhan, China. Covid-19 caused about 33 millions of infection and 1000040 deaths worldwide within 10 months of the pandemic [1]. By December 18th of 2021, number of the infected subjects and deaths rose up to 274 million and 5364119, respectively [2]. Despite its devastating effect on human life, not even a single drug has shown significant enough efficacy against Covid-19 to change the course of the pandemic. However, some new agents and repurposed drugs were able to show efficacy to some extent. In the past 2 years, we have noticed that many Covid-19 cases have actually recovered without any treatment other than general measures. Indeed, most young and middle-aged people survive the disease mildly, yet the disease can be severe in people with advanced age and who have significant additional comorbidities. That’s why, one of the most important things to do while waiting for the pandemic to end is to take and maintain measures to prevent the spread of Covid-19 in societies. Nevertheless, as the outbreak progressed, we began to consider Covid-19-related deaths as ordinary. Unfortunately, we also loosen the tight measures to control the disease.\",\"PeriodicalId\":441304,\"journal\":{\"name\":\"National Journal of Health Sciences\",\"volume\":\"72 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"National Journal of Health Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21089/njhs.62.0044\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"National Journal of Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21089/njhs.62.0044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

大约两年前,在中国武汉出现新型冠状病毒(Covid-19)感染后,到2019年底,世界上数十亿人的生活发生了变化。在大流行后的10个月内,Covid-19在全球造成约3300万人感染和1000040人死亡[1]。截至2021年12月18日,感染人数和死亡人数分别上升至2.74亿人和5364119人[2]。尽管新冠肺炎对人类生命造成了毁灭性的影响,但甚至没有一种药物显示出足够显著的疗效来改变大流行的进程。然而,一些新的药物和重新利用的药物能够显示出一定程度的疗效。我们注意到,近两年来,许多新冠肺炎病例在不采取任何治疗措施的情况下,实际上已经康复。事实上,大多数年轻人和中年人在这种疾病中存活得很轻,但对于老年和有明显其他合并症的人来说,这种疾病可能很严重。因此,在等待大流行结束的同时,最重要的事情之一是采取并维持措施,防止Covid-19在社会中传播。然而,随着疫情的发展,我们开始认为与covid -19相关的死亡是正常的。不幸的是,我们也放松了严格的控制疾病的措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Current Situation in the Struggle against Novel Coronavirus Infection (Covid-19)
The lives of billions in the world have become to change by the end of 2019, almost two years ago, after novel coronavirus (Covid-19) infection emerged in Wuhan, China. Covid-19 caused about 33 millions of infection and 1000040 deaths worldwide within 10 months of the pandemic [1]. By December 18th of 2021, number of the infected subjects and deaths rose up to 274 million and 5364119, respectively [2]. Despite its devastating effect on human life, not even a single drug has shown significant enough efficacy against Covid-19 to change the course of the pandemic. However, some new agents and repurposed drugs were able to show efficacy to some extent. In the past 2 years, we have noticed that many Covid-19 cases have actually recovered without any treatment other than general measures. Indeed, most young and middle-aged people survive the disease mildly, yet the disease can be severe in people with advanced age and who have significant additional comorbidities. That’s why, one of the most important things to do while waiting for the pandemic to end is to take and maintain measures to prevent the spread of Covid-19 in societies. Nevertheless, as the outbreak progressed, we began to consider Covid-19-related deaths as ordinary. Unfortunately, we also loosen the tight measures to control the disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Observed Adverse Effects of Sinopharm COVID-19 Vaccine in Healthcare Workers Undergraduate Nursing Students’ Satisfaction Level with their Clinical Learning Experiences in Multan, Pakistan Evaluation of the Progress of Coronavirus Disease-19 Pneumonia using the British Society of Thoracic Imaging Reporting Model: A Validation Study Surgical Management of Idiopathic Scrotal Elephantiasis: A Rare Case Report Radiomics: A Powerful Tool
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1